Who are CPDN's customers? - the hospitals or the pharmaceutical manufacturers? (3 marks) 2. Do any of the alternatives provided in the case address the root cause of the drug supply shortage problem? (3 marks) 3. What other industries experience supply shortages? How are these problems handled? (3 marks) 4. How much of the drug shortage problem costing CPDN? The members? The Canadian Health Care system? (3 marks) 5. How do you think the Board and the Members react to the four alternatives? Which alternative do you think they will prefer? (4 marks